Intelligent anti-aging skin care based on independent research     
Lose wrinkles, keep your bank account!     
 
Skin Care 101
Skin Care Basics
Skin Protection
Skin Biology
Biology of Aging
Ingredient Guide
Skin & Nutrition
Skin Conditions
 
Anti-Aging Treatments
Topical Actives
Wrinkle Fillers
Noninvasive
Invasive
 
Skin Care Smarts
Smart Choices
Best Practices
Find Good Skin Doc
Quick Tips
Freebie Finder
 
Reviews & Research
Product Reviews
Provider Reviews
Skin Care Research
Clinical Trials
 
How-To Infopacks
Skin Rejuvenation
DIY Skin Care
Skin & Nutrition
Eye Skin Care
Longevity In a Pill
 
Community & Misc
Forums
Polls & Surveys
News and Updates
Search

-- advertisements --
   
You are here: Clinical Trials >

Enhanced Safety Aesthetic Laser System

Information provided by Scilex Ltd.
Information obtained from ClinicalTrials.gov on June 16, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) treated: Hirsutism; Hypertrichosis; Telangiectases; Rhytides

Intervention: Peterio (Device)

Enrollment status: Not yet recruiting

Sponsor: Scilex Ltd.

Principal investigator(s) or official(s):
Leon Gilad, MD, Principal Investigator, Affiliation: Hadassah Medical Center, Dermatology

Overall contact:
Alex Rapoport, BSC, Phone: 972-39506949, Email: alecr@netvision.net.il

Summary

The purpose of this study is to determine whether a new laser system provides better safety and efficacy than existing lasers in popular cosmetic procedures such as hair removal, treatment of cosmetically disturbing vascular lesions and rhytides.

Clinical Details

Official title: Peterio™ – an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments

Study design: Treatment, Non-Randomized, Single Blind, Historical Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Hair, vascular lesions and wrinkles reduction as counted 1-3 months after each treatment session, depending on the treated area.

Secondary outcome: Measuring treatment discomfort as graded by the patients

Detailed description: Cosmetic lasers are a well-established, popular modality for removal of unwanted hair, treatment of all types of vascular lesions, including hemangiomas, port wine stains, and a variety of telangiectases as well as facial rhytides reduction. The existing lasers are based on a wavelength that is specifically absorbed by the chromophore found in the target such as hair follicle, where the energy is converted to heat resulting in a thermal injury. However, the lasers for cosmetic treatments are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. Similar problem exists when targeting other chromophores such as hemoglobin or water. The purpose of the study is an evaluation of safety and efficacy of a new laser based device.

Eligibility

Minimum eligible age: 18 Years. Maximum eligible age: 75 Years. Eligible gender(s): Both.

Criteria:

Inclusion Criteria:

- Age between 18 and 75 years old

- Fitzpatrick skin types I to VI

- Unwanted hair or/and

- Aesthetically disturbing vascular lesions or/and

- Facial rhytides

Exclusion Criteria:

- Age below 18 or above 75 year old.

- Use of photosensitive medications

- Photosensitive diseases

- Active infection of any type and active infection or or a history of Herpes Simplex in

the treated site

- Exposure to sun or artificial tanning during the last 3–4 weeks

- For treatment of facial rhytides- surgical or nonsurgical facial procedure (i. e.,

laser skin resurfacing, dermabrasion, phenol peel, nonablative laser, or temporary/permanent filler (e. g., collagen, fat, hyaluronic acid injections)

Locations and Contact Information

Alex Rapoport, BSC, Phone: 972-39506949, Email: alecr@netvision.net.il

Hadassah Medical Center, Dermatology, Jerusalem 91120, Israel; Not yet recruiting
Leon Gilad, MD, Principal Investigator
Additional Information

Related publications:

Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983 Apr 29;220(4596):524-7.

Start date: September 2007
End date: September 2008
Last updated: July 1, 2007


Google
 
Web SmartSkinCare.com

Home | About Us | Contact Us | Ask a Question | Resources

Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com
Site Disclaimer | Copyright Certification

   
-- advertisements --